Reaction of quercetin (QR) (1) with bromine under various conditions was studied. Interaction of QR with 2-3 equiv. of bromine in glacial acetic acid at 35-40°C for 2-4 h and 20-22°C for 24 h led to the formation of QR 6,8-dibromide (2) (52-54% yields, 96-98% purity by HPLC). Interaction of QR with 2-5 equiv. bromine in absolute ethanol at 0-5°C and 20-22°C for 24 h led to the formation of 3-O-ethyl-QR-2,3,6,8,5'-pentabromide (3) (95-97% purity by HPLC) the output of which depends on the quantity of bromine. It was shown in MDCK cell culture that compound 2 exhibits a moderate inhibitory activity against pandemic influenza virus A/H1N1/ pdm09 (EC 50 6.0 μg/mL, CTD 50 97.7 μg /mL, SI 16). Compound 3 was inactive.
In the plant kingdom, flavonoids are the most abundant and widespread of the polyphenolic natural compounds possessing a broad range of biological and physiological activities (antioxidant, hepato-and gastro protective, anti-inflammatory, anti-allergic, antidiabetic, antiviral, spasmolytic, hypotensive) [1] [2] [3] [4] [5] [6] . Flavonoids play an important role in the antioxidant protection and prevention of oxidative damage in living systems, arising under the influence of various environmental factors (for example, sun exposure and ionizing radiation) [7] [8] [9] . Plant polyphenols are natural inhibitors of carcinogenesis, have cancer protective and anti-tumor properties, and have potential as anticancer agents affecting the growth and transformation of cancer cells in vitro and in vivo, protecting healthy cells from death during chemotherapy and irradiation [10] [11] [12] [13] . In recent years, different groups of flavonoids have attracted increased attention of chemists and pharmacologists in connection with the discovery of their ability to influence the chromatinmodifying enzymes, which makes these classes of natural polyphenols promising agents in the treatment of cancer [14] .
Quercetin (QR) (1) , one of the most famous flavonoids, has P-vitamin activity and has been used in medicine for more than 70 years for the prevention and treatment of various diseases associated with the violation of the permeability and fragility of capillary walls, hypertension, atherosclerosis, asthma, and myocardial infarction as an antioxidant, antispasmodic, antiinflammatory, anti-ulcer and anti-diabetic agent [15, 16] . QR is a natural antioxidant that can neutralize carcinogens causing deformation of DNA, preventing the formation of blood clots and protecting cell membranes from lipid peroxidation; the compound possesses hepatoprotective, anti-inflammatory and anti-cancer properties [8, 11, [17] [18] [19] [20] [21] . Antiviral activity of QR was detected and it was found to inhibit HIV-1 reverse transcriptase and exhibit a virus inhibiting effect against herpes simplex virus [22, 23] . Recently Kim et al. [24] reported that QR has a moderate in vitro activity against influenza A virus (ED 50 48 μM), and isoquercetin exhibits pronounced activity against influenza viruses A and B (ED 50 1.2 μM, TI = 38), and is of interest for medicine as a potential anti-influenza agent.
This work is devoted to the synthesis, identification, and evaluation of the antiviral activity of QR brominated derivatives against influenza virus A /H1N1 in vitro.
Previously, electrophilic reaction of QR with bromine (Br 2 ) has been studied in dioxane and acetic acid to give 6-and 6, 8dibromides [25] . However, in this paper the authors did not give the 13 C NMR spectra of the samples obtained, and chromatographic separation of the reaction products was conducted by paper chromatography, which is obsolete and a rather lengthy method.
We studied reaction of QR with Br 2 under various conditions by using a high performance liquid chromatography (HPLC) analysis of the reaction products. Reaction of QR with an equiv. of Br 2 in glacial acetic acid at 35-40° C for 2 h and 24 h at 20-22°C led to the formation of a mixture of 6,8-dibromide (2) and QR (2:1), which was separated by column chromatography (CC) on silica gel. Output of 2 was 35% (99.0±0.5% purity). Reaction of QR with two equiv. of Br 2 under the same conditions led to 6, 8-dibromide (2) with a purity 85% by HPLC. The formation of 6, 8-dibromide (2) under these conditions corresponds to data published in [25] . The content of the basic substance in the sample was increased after recrystallization from 65% aqueous ethanol and was 95.0±0.5%. Increasing the heating time of reaction up to 4 h resulted in an increased yield of compound 2 (52% yield, 96.0±0.5% purity). Reaction of QR with 3 equiv. of Br 2 led to an increase in yield of compound 2 to 54% and purity to 98.0±0.5%.
The 1 H NMR spectrum of compound 2 contains signals of three protons in a weak field at δ 7.84, 7.68 and 6.94, corresponding to the chemical shifts (CS) of protons H-2', H-6' and H-5', the last being doublets with a vicinal spin-spin interaction constant (SSCC) J = 8.5 Hz. The CS of these protons substantially correspond to the signals of the analogous protons in the 1 H NMR spectrum of the initial QR [26] . In the 13 C NMR spectrum, signals of carbon atoms C-6 and C-8 are observed at δ 93.4 and 87.7, and shifting is observed for those to 4-5 ppm in a stronger field in comparison with the QR spectrum.
Reaction of QR with 2-5 equiv. of Br 2 in absolute ethanol at 0-5°C, followed by holding the reaction mixture at 20-22°C for 24 h resulted in the formation of 2,3,6,8,5'-pentabromide ethyl ether (3), the output of which depends on the quantity of brominating agent. Thus, reaction of QR with 2 and 3 equiv. of Br 2 led to compound 3 with outputs 36 and 52%, respectively. Increasing the amount of Br 2 up to 5 equiv. also led to the formation of compound 3 in 58% yield. Purity of the obtained samples of 3 reached 95-97% by HPLC.
Compound 3 was obtained for the first time. Its structure was confirmed by 1 H NMR and 13 The initial estimation of cytotoxicity and antiviral activity of compounds 2 and 3 against the pandemic strain of influenza virus A/H1N1/pdm09 in MDCK cells culture was carried out by the methods described in [27] . It was shown that compound 2 exhibits a moderate inhibitory activity against influenza A/H1N1 virus. Its 50% inhibitory concentration (EC 50 ) was 6.0 μg/mL, 50% cytotoxic concentration (CTD 50 ) -97.7 μg/mL, and the selectivity index (SI) -16. Compound 3 was inactive (CTD 50 247 μg /mL, EC 50 > 100 μg /mL, SI 2).
Experimental
General: 1 H and 13 C NMR spectra were recorded on Bruker Avance-III 500 and AMX-300 spectrometers in DMSO-d 6 with tetramethylsilane (TMS) as an internal standard. Signals in the 13 C NMR spectra were classified by using a software package ACD LABS and literature data for QR [26] . IR spectra were recorded on an IR Prestige-21 (Shimadzu) spectrometer in a mineral oil paste. Melting points were determined on a Boetius micro table.
HPLC analysis were performed on a Shimadzu LC-20 liquid chromatograph equipped with a reversed-phase column Luna C18 (250 × 4.6 mm) and a spectrophotometric detector SPD-M20 A at a wavelength of 360 nm at 20-22°C in an isocratic elution mode; eluent: acetonitrile-water, 40:60, v/v); flow 1 mL / min. The injected sample was 20 μL at a concentration of 2 mg/mL. The measurement error is ± 0.5%.
TLC was performed on silica gel plates (Sorbfil plates, Sorbpolimer, Russia). Chromatograms were developed by ethyl acetate-ethanol (25:1). Compounds were detected by spraying with 5% H 2 SO 4 solution in ethanol, followed by heating at 110-120°C for 2-3 min. Preparative CC was performed on silica gel KSK SG (fraction 50-150 mesh, dry classification, Sorbpolimer).
Substrates:
Pharmaceutical grade quercetin (UfaVITA) was used for the synthesis. As the reference samples for HPLC analysis, quercetin with a purity of 99% (PhytoPlan®, Heidelberg) and 6,8dibromide 2 (99%) obtained by CC were used. Purification of the solvents was carried out by known techniques [28] .
Synthesis of compound (2)
1. To a solution of quercetin (1, 0.5 g, 1.7 mM) in glacial acetic acid (CH 3 COOH) (40 mL) a bromine solution (0.1 mL, 2 mM, 10 mL CH 3 COOH) was added, and the mixture was heated at 35-40°C for 2 h (until the disappearance of the starting material spot on TLC) and left at 20-22°C for 24 h. The reaction mixture was poured into water, the precipitate filtered off, washed with water, and dried. The crude product (0.45 g) was a mixture of 2 and 1 (2:1), which was purified by CC (silica gel, eluent: benzene-ethanol mixtures, 100: 1, 50: 1, 25: 1, v/v) to give 0.30 g (35%) compound 2 (99.0± 0.5% purity on HPLC), which was used as a standard.
2. To a solution of quercetin (1, 0.5 g, 1.7 mM) in glacial acetic acid (40 mL) a bromine solution (0.2 mL, 4 mM, 10 mL CH 3 COOH) was added and stirred at 35-40°C for 2 h and left at 20-22°C for 24 h. The reaction mixture was poured into water, the precipitate filtered off, washed with water, and dried. The crude product (0.48 g) containing 85.0 ± 0.5% of compound 2 was recrystallized from aqueous (65%) ethanol. Yield 0.34 g (44%, 95.0± 0.5% purity). 
To a solution

Synthesis of compound (3)
1. To a solution of quercetin (1, 0.3 g, 1 mM) in absolute ethanol (15 mL) at 0-5°C a bromine solution (0.1 mL, 2 mM, 10 mL ethanol) was added. The mixture was stirred at 0-5°C for 3 h and left for 24 h at 20-22°C. The resulting solution was poured into water, the precipitate filtered off, washed with water, and dried. Compound 3 (0.26 g) was obtained (36% yield, 95.0 ± 0.5% purity). 
To
Cytoxicity assay:
The microtetrazolium test (MTT) was used to study the cytotoxicity of the compounds. Briefly, a series of twofold dilutions of each compound (1000-4 µg/mL) in MEM were prepared. MDCK cells were incubated for 48 h at 37°C in 5% CO 2 in the presence of the dissolved substances. The degree of destruction of the cell monolayer was then determined with the MTT test. The cells were washed twice with saline, and a solution of 3-(4,5-dimethylthiazolyl-2) 2,5-diphenyltetrazolium bromide (ICN Biochemicals Inc., Aurora, Ohio) (0.5 mg/mL) in saline was added to the wells. After 1 h incubation the wells were washed and the formazan residue dissolved in DMSO (0.1 mL per well). The optical density of cells was then measured on a Victor 2 1440 multifunctional reader (Perkin Elmer, Finland) at a wavelength of 535 nm and plotted against the concentration of the compounds. Each compound concentration was tested in 3 parallels. The 50% cytotoxic dose (CTD 50 ) of each compound (i.e., the compound concentration that causes the death of 50% of cells in a culture, or decreases the optical density twice as compared with the control wells) was calculated from the data obtained.
Antiviral assay:
The compounds in appropriate concentrations were incubated with MDCK cells for 1 h at 37°C. The cell culture was then infected with 10-fold dilutions of the virus (10 -1 -10 -6 ). The plates were incubated for 48 h at 37°C in the presence of 5% CO 2 . The infection activity of the virus was evaluated in a hemagglutination reaction with chicken erythrocytes. A viruscontaining solution (0.1 mL) was placed in the wells of a roundbottom plate. An equal amount of a 1% suspension of chicken erythrocytes in saline was added. The reaction was evaluated after 60 min incubation at room temperature. Each concentration of the compounds was tested in triplicate. A virus titer was considered as the reciprocal to the decimal logarithm of the maximum dilution that caused complete agglutination of erythrocytes and was expressed as logarithms of the 50% tissue culture infection dose (log 10 TCID 50 ). The antiviral activity of the compounds was estimated by the decrease in the virus titer as compared with the control. The 50% effective concentration (EC 50 ) of the drug, that is, the concentration at which the virus production decreased by a factor of 2 (a virus titer per 0.3log 10 EID 50 ) and the selectivity index (SI, the ratio of CTD 50 to EC 50 ) were calculated from the data obtained.
